702 related articles for article (PubMed ID: 28857261)
1. A recombinant iron transport protein from Bordetella pertussis confers protection against Bordetella parapertussis.
Alvarez Hayes J; Oviedo JM; Valdez H; Laborde JM; Maschi F; Ayala M; Shah R; Fernandez Lahore M; Rodriguez ME
Microbiol Immunol; 2017 Oct; 61(10):407-415. PubMed ID: 28857261
[TBL] [Abstract][Full Text] [Related]
2. Outer membrane vesicles derived from Bordetella parapertussis as an acellular vaccine against Bordetella parapertussis and Bordetella pertussis infection.
Bottero D; Gaillard ME; Errea A; Moreno G; Zurita E; Pianciola L; Rumbo M; Hozbor D
Vaccine; 2013 Oct; 31(45):5262-8. PubMed ID: 24012570
[TBL] [Abstract][Full Text] [Related]
3. The O antigen enables Bordetella parapertussis to avoid Bordetella pertussis-induced immunity.
Wolfe DN; Goebel EM; Bjornstad ON; Restif O; Harvill ET
Infect Immun; 2007 Oct; 75(10):4972-9. PubMed ID: 17698566
[TBL] [Abstract][Full Text] [Related]
4. Bordetella pertussis iron regulated proteins as potential vaccine components.
Alvarez Hayes J; Erben E; Lamberti Y; Principi G; Maschi F; Ayala M; Rodriguez ME
Vaccine; 2013 Aug; 31(35):3543-8. PubMed ID: 23731630
[TBL] [Abstract][Full Text] [Related]
5. Do Pertussis Vaccines Protect Against Bordetella parapertussis?
Liko J; Robison SG; Cieslak PR
Clin Infect Dis; 2017 Jun; 64(12):1795-1797. PubMed ID: 28369240
[TBL] [Abstract][Full Text] [Related]
6. Development of vaccines against pertussis caused by Bordetella holmesii using a mouse intranasal challenge model.
Saito M; Odanaka K; Otsuka N; Kamachi K; Watanabe M
Microbiol Immunol; 2016 Sep; 60(9):599-608. PubMed ID: 27515393
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of vaccines against Bordetella parapertussis in a mouse intranasal challenge model.
Komatsu E; Yamaguchi F; Eguchi M; Watanabe M
Vaccine; 2010 Jun; 28(27):4362-8. PubMed ID: 20438876
[TBL] [Abstract][Full Text] [Related]
8. Evolution of French Bordetella pertussis and Bordetella parapertussis isolates: increase of Bordetellae not expressing pertactin.
Hegerle N; Paris AS; Brun D; Dore G; Njamkepo E; Guillot S; Guiso N
Clin Microbiol Infect; 2012 Sep; 18(9):E340-6. PubMed ID: 22717007
[TBL] [Abstract][Full Text] [Related]
9. Bordetella parapertussis survives the innate interaction with human neutrophils by impairing bactericidal trafficking inside the cell through a lipid raft-dependent mechanism mediated by the lipopolysaccharide O antigen.
Gorgojo J; Lamberti Y; Valdez H; Harvill ET; Rodríguez ME
Infect Immun; 2012 Dec; 80(12):4309-16. PubMed ID: 23027528
[TBL] [Abstract][Full Text] [Related]
10. Outer-Membrane-Vesicle-Associated O Antigen, a Crucial Component for Protecting Against
Bottero D; Zurita ME; Gaillard ME; Carriquiriborde F; Martin Aispuro P; Elizagaray M; Bartel E; Castuma C; Hozbor D
Front Immunol; 2018; 9():2501. PubMed ID: 30459769
[No Abstract] [Full Text] [Related]
11. O antigen allows B. parapertussis to evade B. pertussis vaccine-induced immunity by blocking binding and functions of cross-reactive antibodies.
Zhang X; Rodríguez ME; Harvill ET
PLoS One; 2009 Sep; 4(9):e6989. PubMed ID: 19750010
[TBL] [Abstract][Full Text] [Related]
12. The O antigen is a critical antigen for the development of a protective immune response to Bordetella parapertussis.
Zhang X; Goebel EM; Rodríguez ME; Preston A; Harvill ET
Infect Immun; 2009 Nov; 77(11):5050-8. PubMed ID: 19737902
[TBL] [Abstract][Full Text] [Related]
13. Shotgun proteomic analysis of Bordetella parapertussis provides insights into the physiological response to iron starvation and potential new virulence determinants absent in Bordetella pertussis.
Oviedo JM; Surmann K; Gorgojo JP; Valdez H; Dhople VM; Lamberti Y; Völker U; Rodriguez ME
J Proteomics; 2019 Aug; 206():103448. PubMed ID: 31325608
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of the whole-cell pertussis vaccine produced in Poland against different Bordetella parapertussis isolates in the mouse intranasal challenge model.
Zawadka M; Polak M; Rabczenko D; Mosiej E; Augustynowicz E; Lutyńska A
Vaccine; 2011 Jul; 29(33):5488-94. PubMed ID: 21641954
[TBL] [Abstract][Full Text] [Related]
15. Acellular pertussis vaccination facilitates Bordetella parapertussis infection in a rodent model of bordetellosis.
Long GH; Karanikas AT; Harvill ET; Read AF; Hudson PJ
Proc Biol Sci; 2010 Jul; 277(1690):2017-25. PubMed ID: 20200027
[TBL] [Abstract][Full Text] [Related]
16. Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection.
Watanabe M; Nagai M
Infect Immun; 2001 Nov; 69(11):6981-6. PubMed ID: 11598073
[TBL] [Abstract][Full Text] [Related]
17. Pertactin deficient Bordetella pertussis present a better fitness in mice immunized with an acellular pertussis vaccine.
Hegerle N; Dore G; Guiso N
Vaccine; 2014 Nov; 32(49):6597-600. PubMed ID: 25312274
[TBL] [Abstract][Full Text] [Related]
18. Efficacies of whole cell and acellular pertussis vaccines against Bordetella parapertussis in a mouse model.
David S; van Furth R; Mooi FR
Vaccine; 2004 May; 22(15-16):1892-8. PubMed ID: 15121300
[TBL] [Abstract][Full Text] [Related]
19. Bordetella parapertussis infections.
Mastrantonio P; Giuliano M; Stefanelli P; Sofia T; De Marzi L; Tarabini G; Quarto M; Moiraghi A
Dev Biol Stand; 1997; 89():255-9. PubMed ID: 9272358
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of a whole cell pertussis vaccine and fimbriae against Bordetella pertussis and Bordetella parapertussis infections in a respiratory mouse model.
Willems RJ; Kamerbeek J; Geuijen CA; Top J; Gielen H; Gaastra W; Mooi FR
Vaccine; 1998 Feb; 16(4):410-6. PubMed ID: 9607064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
